FemRx focuses on women's health
This article was originally published in Clinica
FemRx aims to establish leadership in the device market for women's health. President and CEO Andrew Thompson told Clinica that the company is solely focused on solving gynaecological problems - a rarity among medical technology companies.
You may also be interested in...
To be more transparent and allow more public discourse, the HHS now requires all its agencies to publish documents it uses to rationalize proposed rules and demonstration projects.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.